Search clinical trials for: Rituximab plus CHOP
Total 8223 results
-
Fudan UniversityCompletedDouble Expressor LymphomaChina
-
Peking UniversityUnknownChemotherapy Effect | Esophageal Cancer, Squamous Cell | Cetuximab EffectChina
-
University of TorontoActive, not recruiting
-
Weill Medical College of Cornell UniversityBayerCompletedT-Cell Lymphoma | Lymphoma, Non-Hodgkin'sUnited States
-
Thomas MorlandNot yet recruiting
-
PfizerCompletedRheumatoid ArthritisUnited States, Australia, Canada, Israel, Mexico, Colombia, Germany, Russian Federation, South Africa, United Kingdom
-
Dana-Farber Cancer InstituteGenentech, Inc.RecruitingRichter SyndromeUnited States
-
AmgenCompletedChronic Kidney Disease | Chronic Renal Insufficiency | Kidney Disease | Pre-dialysis | Pre-ESRD
-
AmgenCompletedCancer | Non-Myeloid Malignancies
-
Mabion SAParexelWithdrawn
-
Zhejiang Cancer HospitalRecruitingDiffuse Large B Cell LymphomaChina
-
First Affiliated Hospital of Wenzhou Medical UniversityRecruitingDiffuse Large B Cell LymphomaChina
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
The Catholic University of KoreaActive, not recruitingLymphoma, Large B-Cell, DiffuseKorea, Republic of
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); Hamilton Academic Health Sciences...CompletedCardiovascular Diseases | Diabetes MellitusCanada
-
National Institute of Allergy and Infectious Diseases...Genentech, Inc.; Immune Tolerance Network (ITN)CompletedVasculitis | Wegener's Granulomatosis | Microscopic PolyangiitisUnited States, Netherlands
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Recurrent Chronic Lymphocytic LeukemiaUnited States
-
Erica GoldsteinCompletedDietary SupplementationsUnited States
-
National Cancer Institute (NCI)Celgene CorporationActive, not recruitingAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
Genzyme, a Sanofi CompanyCompletedHodgkin Disease | Non-Hodgkin LymphomaUnited States
-
Regina Elena Cancer InstituteUniversity of Rome Tor Vergata; Campus Bio-Medico University; Sant'Eugenio Hospital...RecruitingMultiple MyelomaItaly
-
University of MichiganEmory University; University of California, San Francisco; Research Foundation...CompletedHIV Infections | HIV Primary InfectionUnited States
-
Philip Morris Products S.A.Completed
-
DEKK-TEC, Inc.National Cancer Institute (NCI)CompletedAdvanced Cancer | Brain InvolvementUnited States
-
DEKK-TEC, Inc.National Cancer Institute (NCI)CompletedAdvanced CancerUnited States
-
Miltenyi Biomedicine GmbHICON plcRecruitingDiffuse Large B-cell LymphomaSpain, Germany, Netherlands, Belgium, France, Czechia, Austria, Lithuania, Sweden, Hungary, Italy, Poland
-
RTI InternationalDurham County Department of Public Health; Guilford County Department of Public... and other collaboratorsTerminatedHuman Immunodeficiency Virus (HIV) | Condomless Sex | Alcohol and Drug Use | Sexually Transmitted Infection (STI)United States
-
Lymphoma Study AssociationEli Lilly and Company; Hoffmann-La Roche; Sanofi-SynthelaboCompletedDiffuse Large Cell LymphomaFrance
-
Peking UniversityRecruitingNodal T-follicular Helper Cell LymphomaChina
-
Qure Healthcare, LLCLineagenCompletedIntellectual Disability | Developmental DelayUnited States
-
Fondazione Italiana Linfomi - ETSActive, not recruitingLymphoma | Large B-Cell | Diffuse Large B-CellItaly
-
National Cancer Institute (NCI)RecruitingNodular Lymphocyte Predominant B-Cell Lymphoma | Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma | Refractory Nodular Lymphocyte Predominant B-Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
University of South CarolinaNational Cancer Institute (NCI); American Cancer Society, Inc.CompletedBreast CancerUnited States
-
The Affiliated Hospital of Qingdao UniversityNot yet recruitingChildren | Blood Disease | Rituximab
-
Alaunos TherapeuticsWithdrawn
-
Heart and Diabetes Center North-Rhine WestfaliaCompleted
-
Azidus BrasilSichuan Yuanda Shuyang Pharmaceutical Co., Ltd.Not yet recruitingPrimary Immunodeficiency Disease
-
University of ConnecticutCompletedCognitive DysfunctionUnited States
-
M.D. Anderson Cancer CenterRecruitingRefractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Richter Syndrome | Refractory Mantle Cell Lymphoma | Refractory Aggressive B-Cell Non-Hodgkin Lymphoma | Refractory High Grade B-Cell Lymphoma | Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Refractory... and other conditionsUnited States
-
First Affiliated Hospital of Zhejiang UniversityUnknown
-
National Cancer Institute (NCI)Active, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
The University of Tennessee, KnoxvilleNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Cherokee...CompletedObesity | Childhood ObesityUnited States
-
ResMedCompletedSleep Apnea, Obstructive | Sleep Apnea, CentralGermany
-
Sunnybrook Health Sciences CentreQueen's University; The Leukemia and Lymphoma SocietyRecruitingLymphoma | Chemotherapeutic ToxicityCanada
-
BaycrestHealth and Stroke Foundation-Canadian Partnership for Stroke recoveryCompleted
-
The Miriam HospitalBrown UniversityUnknownFatigue | Cancer SurvivorshipUnited States
-
University Hospital, ToulouseCompletedAutoimmune Diseases | Renal TransplantFrance
-
Hospital Arnau de VilanovaCompletedGestational Diabetes Mellitus (GDM)Spain
-
M.D. Anderson Cancer CenterActive, not recruitingMantle Cell LymphomaUnited States